Joint Formulary & PAD

Imiquimod - Actinic keratosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Cream
Associated Icons :
Restrictions / Comments :
Important

Imiquimod 5% cream

Primary care iniatiation only on recommendation from dermatology specialist team.

 

Status 2

Non Formulary
Formulations :
  • Cream
Associated Icons :
Restrictions / Comments :
Important

Imiquimod 3.75% cream (Zyclara) - not to be prescribed. The 5% cream is a more cost-effective option.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Imiquimod
Indication :
Actinic keratosis
Group Name :
Keywords :
Brand Names Include :
Aldara
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

Imiquimod 5% should only be initiated on specialist advice.

The APC has made recommendations for the primary care treatment choices for actinic keratosis - see treatment guidelines

Other Indications

Below are listed other indications that Imiquimod is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Actinic keratosis.